These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8170206)

  • 1. Hepatotoxicity of 6-mercaptopurine and azathioprine.
    Gross R
    Mayo Clin Proc; 1994 May; 69(5):498. PubMed ID: 8170206
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
    Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
    J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-mercaptopurine as an alternative to azathioprine in azathioprine-induced hepatoxicity.
    Kiefer K; El-Matary W
    Inflamm Bowel Dis; 2009 Feb; 15(2):318-9. PubMed ID: 18989893
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
    van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
    J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
    Andrejic J; Rojas-Balcazar J; Dennis M; Berkelhammer C
    Inflamm Bowel Dis; 2010 Nov; 16(11):1828-9. PubMed ID: 20196148
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
    Shaye OA; Yadegari M; Abreu MT; Poordad F; Simon K; Martin P; Papadakis KA; Ippoliti A; Vasiliauskas E; Tran TT
    Am J Gastroenterol; 2007 Nov; 102(11):2488-94. PubMed ID: 17764490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.
    Wong DR; Coenen MJ; Derijks LJ; Vermeulen SH; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
    Aliment Pharmacol Ther; 2017 Feb; 45(3):391-402. PubMed ID: 27943397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
    Broekman MMTJ; Coenen MJH; van Marrewijk CJ; Wanten GJA; Wong DR; Verbeek ALM; Klungel OH; Hooymans PM; Guchelaar HJ; Scheffer H; Derijks LJJ; de Jong DJ;
    Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.
    Gisbert JP; González-Lama Y; Maté J
    Am J Gastroenterol; 2007 Jul; 102(7):1518-27. PubMed ID: 17391318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable azathioprine hepatotoxicity: a case report.
    Small P; Lichter M
    Ann Allergy; 1989 Jun; 62(6):518-20. PubMed ID: 2735558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.
    Mistilis SP; Blackburn CR
    Australas Ann Med; 1967 Nov; 16(4):305-11. PubMed ID: 6080446
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology.
    Markowitz JF
    Inflamm Bowel Dis; 1998 May; 4(2):117-8; discussion 118-20. PubMed ID: 9687220
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Azathioprine and liver disease.
    Koretz RL
    Arch Intern Med; 1974 May; 133(5):869-70. PubMed ID: 4595401
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
    Marion JF
    Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
    Laidlaw ST; Reilly JT; Suvarna SK
    Postgrad Med J; 1995 Oct; 71(840):639. PubMed ID: 8545299
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
    Stuckert AJ; Schafer ES; Bernhardt MB; Baxter P; Brackett J
    Leuk Lymphoma; 2020 May; 61(5):1246-1249. PubMed ID: 31842647
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible liver damage after azathioprine.
    Zarday Z; Veith FJ; Gliedman ML; Soberman R
    JAMA; 1972 Nov; 222(6):690-1. PubMed ID: 4562099
    [No Abstract]   [Full Text] [Related]  

  • 18. Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.
    Jeurissen ME; Boerbooms AM; van de Putte LB; Kruijsen MW
    Ann Rheum Dis; 1990 Jan; 49(1):25-7. PubMed ID: 2138007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
    Griffiths AM
    Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
    [No Abstract]   [Full Text] [Related]  

  • 20. Sperm, sex, and 6-MP: the perception on conception.
    Cohen RD
    Gastroenterology; 2004 Oct; 127(4):1263-4. PubMed ID: 15481005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.